The frequency of the HLA-DR4-DQ4 haplotype (DRB1*0405-DQA1*0302-DQB1*0401) is significantly increased in Japanese patients with rheumatoid arthritis (RA) and DRB1*0405-binding peptide motifs were identified in our previous studies. To clarify the DQ4-binding peptide motifs, the primary structure of DQ4-binding peptides was determined by affinity-based selection of a phage random peptide library. Analog peptides of a high-affinity DQ4 binder revealed that two major anchors (VxxxxxxxR; where x is any amino acid) play an essential role in binding to DQ4. The affinity of synthetic VAAAAAAAR-based analog peptides showed that substituting V to W, G, L, I, M, P, F, Y or A, and R to H, M, L, I or V allows binding. The involvement of the ninth residue of the peptides, especially Arg, was critical for high-affinity binding. In comparison with other class IIbinding peptide motifs reported to date, peptide motifs for DQ4 were unique, in that Gly and Pro are allowed as low-affinity N-terminal anchors. Interestingly, 94 putative DQ4-binding motifs were detected in the human type II collagen molecule, since it is composed of (Gly-X 1 -X 2 ) n and is rich in R and P at positions X 2 . However, no significant differences were observed between the affinities of the collagen-derived peptides with DR or DQ molecules of RA-susceptible DR4-DQ4 and with those of non-susceptible DR4-DQ8 (DRB1*0406-DQA1*0301-DQB1*0302) haplotypes, indicating that the susceptibility to RA is not a simple immune response gene phenomenon specific to collagen. The immunogenetic implications of the unique peptide motifs for DQ are discussed.
Introduction
It is generally accepted that T cells play an important role in the development of rheumatoid arthritis (RA) (1) . Some antigens, such as type II collagen and heat-shock protein, are reportedly recognized by the synovial T cells in the context of self class II MHC molecules (2, 3) . Of these, type II collagen might be directly associated with the development of RA as a major autoantigen recognized by T cells since: (i) there are autoantibodies directed against type II collagen in the serum and joint fluid of a significant percentage of patients with RA with evidence for local production in joints (4); (ii) it is possible to induce a genetically determined chronic arthritis that resembles RA by immunization with type II collagen in experimental animals (guinea pigs, rats, mice, and rhesus and cynomolgus monkeys) (5, 6) ; (iii) T cells obtained from the affected synovium of RA subjects reacted with type II collagen (3); (iv) TCR Vp usage of T cells in synovial fluids (7) (8) (9) (10) and peripheral blood (11) showed oligoclonal patterns, suggesting the involvement of a limited set of autoantigens and/or superantigens; and (v) oral administration of chicken collagen molecules ameliorated RA (12) .
From a genetic standpoint, a polygenic control mechanism has been proposed for the development of RA. It is especially important to note that RA is strongly associated with some DR4 subtype molecules including DRB1*0401 in Caucasians (13) , raising the possibility that autoantigens in RA are presented to T cells in the context of class II HLA molecules of these haplotypes. In Japanese patients with RA, DRB 1*0401, although significantly high in frequency, carries a lower risk for RA than DRB1*0405, which is the most common DR4-associated DR subtype (30 and 70% in healthy and RA subjects respectively), yet it is also unique to orientals (13) . However, due to the strict linkage disequilibrium of the DRB1*0405 gene with the DQ4 (DQA1*0302/DQB1*0401) genes, it is difficult to determine which class II complex is primarily associated with the susceptibility to RA.
In our previous studies (14) , we identified three anchor positions on DR4-binding peptides important for binding to DR4 (DRB1*0405 and DRB1*0406) and the allele specificity of structural requirements for peptides bound to these DR4 molecules. These data successfully predicted a T cell epitope on the human insulin molecule in insulin autoimmune syndrome which is strictly associated with DRB1*0406 (14) . In the current study, we determined binding peptide motifs for HLA-DQ4, a class II molecule encoded for by HLA-DQA1*0302 and DQB1*0401 genes in tight linkage disequilibrium with the DRB1*0405 gene, by using a phage random peptide library with 15-mer peptide inserts on N-termini of pill minor coat protein molecules. Based on these results, we compared the binding affinity of human type II collagenderived peptides positive for DR4-or DQ4-binding motifs with DR and DQ molecules of RA-susceptible (DR4-DQ4 or DRB1*0405-DQA1*0302-DQB1*0401) and non-susceptible (DR4-DQ8 or DRB1*0406-DQA1*0301-DQB1*0302) haplotypes.
Methods

Construction of the 15-mer random peptide library
The library was constructed essentially as described (15) , with some modifications (manuscript in preparation). Bacteriophage fUSE5 vector and Escherichia coli K91 and MC1061 were kindly provided by Dr G. Smith (University of Missouri). A mixture of oligonucleotides encoding for possible 15 amino acid peptides was synthesized with the sequence 5'-ACTCGGCCGACGGGGCT(NNK) 15 GGGGCCGCTGGGGCC-GAA-3' (TN-1), in which N stands for an equal mixture of G, A, T and C, and K stands for a equal mixture of G and T. TN-1 single-stranded degenerative oligonucleotides were converted to double-stranded DNAs by PCR amplification with 5'-biotinylated primers (TN-2: 5'-ACTCGGCCGACG-GGGC-3', identical to the 5' end of TN-1; and TN-3: 5'-TTCGGCCCCAGCGGCCC-3', complementary to the 3' end of TN-1). The double-stranded DNA fragments were digested with Bgl\ and small fragments from both ends were absorbed by mixing with Streptavidin-agarose beads. The Sffl-digested fUSE5 vector was ligated with purified Bg/l-digested 63 bp inserts. Competent MC1061 cells were transformed with the ligated DNAs using electroporation and grown in culture medium containing tetracycline through -10 doublings at 37°C to amplify the library. Phages from liquid culture were obtained by clearing the supernatant, precipitating phage virions with polyethylene glycol, followed by CsCI 2 gradient and simple ultracentrifugations. The final phage pellet was dissolved in 1.5 ml Tris-buffered saline containing 0.02% NaN 3 . This library consisted of 3.7x10 8 independent phage particles displaying 15 random amino acid peptides flanked on the N-terminus by NH 2 -ADGA-and on the C-terminus by -GAAGA-. The flanking sequences are intended to be structureless linkers to minimize the influence of pill on peptide conformation.
Isolation and biotinylation of HLA-DQ4
Epstein-Barr virus-transformed human B lymphoblastoid cell lines EBWa homozygous for the HLA-DR4 (DRB1*0405)-DQ4 (DQA1*0302-DQB1*0401) haplotype were lysed as described elsewhere (14) . After preclearing the lysate with Protein A-Sepharose and HU-4 anti-DR Sepharose (14) , DQ4 molecules were purified by affinity chromatography with mAb HU-46 (anti-DQ4 lgG2a; 16). The HU-46 Sepharose eluate (pH 10.5) was immediately neutralized by adding 1/20 volumes of 0.5 M NaH 2 PO 4 and centrifuged in a Centricon-10 (10 kDa cutoff; Amicon, Danvers, MA). The concentrate was exchanged to 0.25 M NaHCC>3/0.2% NP-40 by repeated addition of the buffer and centrifugation. The preparation thus obtained contained 5 ng of DQ molecules and was subjected to biotinylation. Unbound biotin was removed by five cycles of centrifugation on a Centricon with the addition of 50 mM Tris-HCI, pH 7.5, 150 mM NaCI, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride/0.2% NP-40. The HLA-DQ8 molecules (DQA1*0301-DQB1*0302) were purified from KT13 cells (14) in the same manner by using mAb HU-18 (anti-DQ3 lgG2a; 17).
Library screening
One hundred billion phage particles (6X10 9 transducing units) of the amplified fUSE5 peptide library were incubated with 1 ng of biotinylated DQ4 complexes (10 13 molecules) for 24 h at room temperature. The mixture was then applied to an avidin-coated and BSA-blocked 35 mm polystyrene Petri dish (Falcon, Becton, NJ) and incubated for 10 min at room temperature with continuous stirring. After extensive washing with 0.5% Tween 20/Tris-buffered saline (pH 7.5), the bound DQ4-phage complexes were eluted with 400 nl of 0.1 M glycine-HCI, pH 2.2. The neutralized eluate was concentrated and exchanged to Tris-buffered saline and used to infect E. coli K91 kan cells, which were then amplified in the presence of tetracycline. Phage particles were harvested and purified three times with polyethylene glycol. The screening procedure was repeated twice. The eluate of the third round was used to isolate and sequence individual fUSE5 clones by using 5'-TGAATTTTCTGTATGAGG-3' as a sequencing primer.
Synthesis of peptides
All peptides used for the binding assay were synthesized by a solid-phase simultaneous multiple peptide synthesizer DQ4-binding peptide motifs 759 The phages were selected from the fUSE5 random peptide library by DQ4 molecules and isolated after three rounds of screening. Superscripts indicate synthetic peptides tested which resulted in a positive (>5%) and b marginal (<5%) binding to DQ4.
PSSM-8 (Shimadzu, Kyoto, Japan) based on the Fmoc strategy and purified by C18 reverse-phase HPLC. Peptides DQ4BP6 (VEGPVYDAVVNMLRR) and VAAAAAAAR were sequenced to confirm their structure.
Class II HLA-peptide binding assay
The class II HLA-peptide binding assay was performed as described elsewhere based on competitive inhibition assay (14) . Purified HLA molecules were incubated for 48 h with 20 nM of radioiodinated DQ4BP6 or DRB1*0405-binding 0405BP3 (GSTVFDNLPNPEIDGDYYGW) for binding with DQ4 and DR4 respectively with various doses of various unlabeled peptides at pH 7.0 in the presence of a protease inhibitor cocktail (14) . When peptide binding to DQ4 and DQ8 were compared, [ 125 I]KLYAAAAAAR was used. The HLA-peptide complexes were separated from free peptides by gel filtration and fractions were assayed for radioactivity. The peptide fraction which bound to HLA molecules was calculated as the ratio of peptide in the void volume to the total peptide recovered. The data were then plotted and the concentrations of unlabeled peptides which yielded 50% inhibition of binding (IC 50 ) were determined.
Results
Insert sequences and direct binding assay
Phage particles carrying 15-mer random peptide sequences were selected by incubation with biotinylated DQ4 complex followed by panning on an avidin-coated plate. Eluted particles after the third round of panning were clonally expanded and peptide insert sequences were determined by DNA sequencing. As shown in Table 1 , 68 independent sequences were obtained. Of these, 12 peptides in their native sequences, or with insertion of a Tyr residue at the C-terminus, were radioiodinated and tested for direct binding to the purified DQ4 complex. Of the 12 peptides tested, 10 showed >5% binding (i.e. c.p.m. in high molecular weight range/total c.p.m. recovered by gel filtration >5%), whereas an irrelevant DR4-binding peptide (EGQLVSIHSPEEQDFLTKHAY; 14) revealed only 0.2% binding. Among these, peptide DQ4BP6 (VEGPVYDAVVNMLRR) showed the highest binding (10.6%). The binding affinity of DQ4BP6 at pH 4 was lower than that at pH 7 (not shown). Scatchard plot analysis revealed the dissociation constant of DQ4-DQ4BP6 binding to be 147 nM (not shown).
Identification of anchor residues
To identify the anchor positions of DQ4BP6 (VEGPVY-DAVVNMLRR 15 ) for binding to the DQ4 complex, we synthesized a series of non-conservatively modified peptides of DQ4BP6 with the hydrophilic and the hydrophobic residues substituted to Ala and Ser respectively (14) . As shown in Fig.  1(a) , only two non-conservative substitutions ( N were substituted nonconservatively. To confirm whether or not the two residues (Val and Arg) are enough for high-affinity binding to DQ4, we synthesized a polyalanine-based 10-mer analog (VAAAAAA-AAR = VA 8 R) and a series of related peptides and tested their affinity to the DQ4 complex, as shown in Fig. 1(b) . 
Single amino acid substitution of primary anchors
To identify other structural motifs, peptides with substitutions of the V or R residues of VA 7 R to R, K, H, E, D, Q, N, T, S, C, G, A, V, L, I, F, M, W, Y or P were synthesized and evaluated by binding inhibition assay with DQ4. For quantitative evaluation, the IC 50 for each peptide was determined, where a lower value indicates better binding. As shown in Fig. 2 , substitutions of both anchors caused marked variation in the IC 50 values. Thus, only hydrophobic residues at the N-terminal anchor (P1) showed detectable binding to DQ4, whereas some basic, Met and large aliphatic residues at the C-terminal anchor (P9) permitted binding. Among P9 anchor residues, Arg gave the strongest affinity to DQ4 molecules. It is also important to note that Gly and Pro are tolerated at P1 for hydrophobic interaction with the pocket, unlike the DR-binding peptide motifs reported previously. Thus, IC 50 values of GAAAAAAAR and PAAAAAAAR for binding to DQ4 are 125 and 75 nM respectively (Fig. 2) , although Gly and Pro at P1 exhibited >500 \iM of IC50 for binding to DR4 (14) . None of other peptide motifs for DR reported to date revealed positive involvement of Gly or Pro at P1.
Binding of human type II collagen fragments to DR and DQ molecules
The positive involvement of Gly and Pro at the N-terminal anchor and of Arg at the C-terminal anchor may give rise to multiple DQ4-binding peptide fragments on type II collagen, the most likely self-antigen responsible for RA (2-12), because collagen consists of Gly-X r X 2 repeats with high frequencies of Pro at XT or X 2 , and Arg at X 2 . As expected, type II collagen was abundant in putative DQ4-binding GxxGxxGxR (46 fragments) and PGxxGxxGXI (21 fragments) sequences. The xxGxxGxxG motif is not allowed because when Gly is the C-terminal anchor, binding with DQ4 is not detected. Other putative binders had the X 2 GxxGxxGX! (27 fragments) motif with X 2 being hydrophobic residues other than Pro and X 1 being R, H, M, L, I or V. To test their actual binding to DQ molecules, representative type II collagen peptides that cover all the motif patterns were synthesized. Because DQ4BP6 did not bind to DQ8 (DQA1*0301-DQB1*0302) as strongly as to DQ4, we tested direct DQ binding of some polyalanine-based peptides and found that KLYAAAAAAR (KLYA 6 R) bound to DQ4 and DQ8 with virtually equal high affinity (not shown). The DQ4-DQ4BP6 affinity and DQ4-KLYA6R affinity were practically the same. Lys and Tyr were inserted for higher solubility and radioiodination, because Lys is not allowed as an N-terminal anchor and P2 of DQ4BP6 was Tyr. By coincubating DQ molecules, [ 125 l]KLYAeR and collagen-derived putative binders, affinity to DQ4 and DQ8 was determined. As shown in Table 2 , 23 out of 27 peptides showed detectable binding to DQ4, but significant allele specificity in binding was not observed. It is important to note that most peptides showed low to intermediate affinity to DQ4 with the lowest IC50 being as high as 110 \iM.
Putative type II collagen-derived peptide fragments that bind to RA-susceptible HLA-DR4 (DRB1*0405) were selected based on IC 50 values of AAFAALANAA-based analog peptides demonstrated in our previous studies (14) . To avoid missing low-affinity binders, residues at anchor positions that meet the following criteria were selected: (i) IC50 values of the AAX,AALANAA, AAFAAX 2 N and D) . Six peptide fragments with the YxxLxG, VxxIxP, FxxLxG and MxxMxP motifs fit these criteria, and their affinity to DRB 1*0405 as well as RA-non-susceptible DRB1*0406 were determined. As shown in Table 3 , binding to DRB 1*0405 was detected with three peptides and the binding of all of these peptides with DRB1*0406 was virtually identical.
Discussion
In the studies herein, we have identified binding peptide motifs for DQ4 of an RA-susceptible HLA haplotype DR4 (DRB1*0405)-DQ4 (DQA1*0302-DQB1*0401) and showed that Arg at P9 is essential for high-affinity binding, which is not the case for most of the DR molecules.
We tried to align the insert sequences shown in Table 1 for the identification of secondary anchors. Fifty-seven out of 68 peptides (84%) fit in the primary anchor motifs shown in Fig.  2 . However, when the regions flanked by random inserts are also taken into consideration, all but one peptide (FTAFGFSE-QRTFAER) fit in the 9-mer motif demonstrated in Fig. 2 , since sequences such as APLSGHSSV can use the N-terminal Ala at the non-random region as a first anchor. Many insert sequences had more than two motifs and aligning all of these 9-mer frames did not reveal any residue selectivity at any positions. The only one peptide FTAFGFSEQRTFAER that could not be explained by the 9-mer motifs, has 10-mer motifs as underlined, which is reminiscent of the DQ4BP6 peptide shown in Fig. 1 . Moreover, through our recent study with DQ9 (DQA1*0301-DQB1*0303), the 8-mer motif is. also used for high-affinity binding with DQ molecules (manuscript in preparation). These data collectively suggest that: (i) conformation of DQ-binding peptides might be different from that of DR-binding peptides (19) which form a type II polyproline helix-like conformation, rather resembles class I MHC-binding peptides with kinking or bulging (18) since there are no substantial anchor positions interacting with the central part of the groove of DQ4; and (ii) it might be difficult to identify anchor residues for DQ-binding peptides by simply aligning the peptide sequences, because non-9-mer frames are frequently observed. The evolution of the MHC as a multigene family might function to accommodate various protein fragments with different conformation or chemical characteristics. Indeed, DP-binding peptide motifs reported by others (20) are unique, in that they allow basic residues at P1.
With regard to the C-terminal anchor, 57 p is reportedly one of the most important polymorphic sites interacting with P9. A direct association between the polymorphism in 57 p and the susceptibility to diabetes has been shown in non-obese diabetic mice (21) ; such an association has also been reported P is critical in the development of diabetes (24) .
We have also clarified that DQ but not DR molecules of an RA-susceptible HLA haplotype DR4 (DRB1*0405)-DQ4 (DQA1*0302-QB1*0401) can bind multiple fragments of type II collagen with low to intermediate affinity, because: (i) Gly and Pro are allowed as primary anchors unlike the other class ll-binding peptide motifs; and (ii) type II collagen is rich in Arg. The HLA-DR pocket interacting with P1 is reportedly very hydrophobic (23), so is probably the case for HLA-DQ4 judging from our data. It is conceivable that non-polar Gly at P1 of GxxGxxGxR, regardless of its small side chain, is allowed for hydrophobic clustering in the presence of polar solvent, i.e. H 2 O, and created detectable binding affinity with Arg at P9. Indeed, the IC 50 values of these peptides were relatively high as expected from Fig. 2 . However, peptides with IC 50 values >100 |iM can effectively stimulate a human T h 1 clone in the context of DR4 (14, Chen et al., unpublished results). On the contrary, fewer collagen-derived peptides bound to DR, but with higher affinity than to DQ. Furthermore, none of these peptides showed differential binding to susceptible and non-susceptible DR or DQ molecules. These data collectively indicate that: (i) both DR and DQ might be able to function as type II collagen-presenting molecules; and (ii) the susceptibility to RA is not a simple immune response gene phenomenon specific to type II collagen.
In this regard, it is interesting to note that I-A molecules, which have the highest sequence homology with DQ among HLA class II molecules, are primarily involved in the development of collagen-induced arthritis (25) and recent studies by Miyahara et al. (26) clearly showed that murine T cells specific to type II collagen recognize GxxGxxGxR as a core sequence in the context of I-A. Furthermore, Nabozny etal. demonstrated that murine class ll-knockout, DQ-transgenic mice developed severe arthritis after immunization with type II collagen (27) . It is important to note that certain DQ alleles are in linkage disequilibria both with RA-susceptible and non-susceptible DR alleles, suggesting the possible genetic epistasis (28) of DR. For instance, DQ8 (DQA1*0301-DQB1*0302) is linked with RA-susceptible DRB1*0401 in Caucasians and Asian Indians, but with non-susceptible DRB1*0406 in orientals. The frequency of HLA-DR-and HLA-DQ-restricted precursor T cells, e.g. those specific to type II collagen in patients with RA, awaits to be determined.
Recent studies on DRB1*0405 and 0406 by ourselves (14) , and on DRB1*0401, 0402 and 0404 by Hammer et al. (29) identified differential binding of some peptides. However, in the latter study, the criteria of RA-susceptible and nonsusceptible DRP sequences does not apply for DRB 1*0405 and 0406 (14) . Furthermore, candidate procollagen sequences with possible differential binding are all derived from the propeptide moiety (29), which is not included in the purified arthritogenic collagen preparation in murine systems. Provided that none of the peptide fragments of diseaserelated autoantigens, such as type II collagen, differentially bind to class II HLA molecules of the disease-susceptible and non-susceptible haplotypes, the difference in the susceptibility associated with HLA alleles may be attributable not to the autoantigen-specific immune response genes, but to other mechanisms, such that: (i) susceptible and non-susceptible haplotypes function differently in the induction of tolerance (30); (ii) DQ4-peptide and DQ8-peptide complexes activate a different repertoire of T cells with different roles in developing RA; (iii) mechanisms other than HLA-peptide affinity determine immunodominance; and (iv) T cell responses to autoantigens might be preceded by some other antigen-induced immune responses mediated by the disease-susceptible HLA molecules, which render the microenvironment IL-2-rich to break tolerance (31) .
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suggests that affinity cannot be predicted from motifs based on primary structure alone. Observations by others (32, 33) that certain residues exert a dominant negative effect on HLApeptide binding might be explained by such a mechanism. For more detailed analyses, the effect of post-translational modifications of collagen such as hydroxylation and glycosylation (34) on peptide binding to HLA-DR or DQ might need to be additionally considered.
